articleTop 10% cited
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
Virology · 1991 · Vol. 185(1) · pp. 251–257
Plant Virus Research StudiesCervical Cancer and HPV ResearchPoxvirus research and outbreaksBiologyRecombinant DNAVacciniaVirologyHuman papillomavirusMolecular biologyCell biologyGeneGenetics
MeSH terms
AnimalsBase SequenceCell LineGenes, ViralGlycosylationHumansMicroscopy, ElectronMolecular Sequence DataMolecular WeightOligodeoxyribonucleotidesOncogene Proteins, ViralPromoter Regions, GeneticRecombination, GeneticVaccinia virusVirion
Funding
- Hospital Research Foundation
- PA Research Foundation
- National Health and Medical Research Council
- National Medical Research Council
Citations
503
FWCI
13.08
field-weighted impact
References
36
Percentile
99%
vs. same field & year
Citations per year
Cited by
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
Journal of Clinical Oncology · 2006 · 3,448 citations
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
The Lancet Oncology · 2005 · 1,577 citations
Papillomaviruses and cancer: from basic studies to clinical application
Nature reviews. Cancer · 2002 · 3,997 citations
Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
Cancer Letters · 2019 · 499 citations
Immune responses to human papillomavirus
Vaccine · 2005 · 589 citations
References
DNA sequencing with chain-terminating inhibitors
Proceedings of the National Academy of Sciences · 1977 · 69,196 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.